International Patent: HUMAN NERVE GROWTH FACTOR PHARMACEUTICAL COMPOSITION AND USE THEREOF

GENEVA, June 26 -- SHENYANG XINGQI PHARMACEUTICAL CO., LTD. filed a patent application (CN2025/138425) for “HUMAN NERVE GROWTH FACTOR PHARMACEUTICAL COMPOSITION AND USE THEREOF”. With publication no. WO/2026/119025, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 38/18

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....